Asthma
Conditions
Interventions
Acupoint injection group:Patient in acupoint injection group was given Shenfu injection at Feishu, Dingchuan, Shenshu, Zusanli, 1ml per acupoint, 3 times a week for 4 weeks.
Conventional Medicine Group:theophylline sustained-release tablets twice a day, one tablet each time.
Acupuncture:The acupuncture group was treated with Feishu, Dingchuan, Shenshu and Zusanli, 3 times a week for 4 weeks.
Sponsors
Rehabilitation Hospital, National Research Center for RehabilitationTechnical Aids
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18-80 years; (2) Acupuncture treatment has not been performed for nearly one month; (3) The patient meet the diagnostic criteria for bronchial asthma and are in chronic duration or clinical remission; (4) The patient or family member agreed to participate in the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women; (2) Those who are allergic to traditional Chinese medicine such as aconite and red ginseng; (3) Critically ill patients with bronchial asthma; (4) Patients with tuberculosis, bronchiectasis, pneumoconiosis, silicosis, bronchial lung cancer, allergic lung infiltration or other pulmonary diseases; (5) Patients with medical, liver, and kidney-related diseases or severe immune-related diseases and mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma Control Test; | — |
Secondary
| Measure | Time frame |
|---|---|
| FEV1%, PEF, FEV1/FVC;Ige;Counts of EOS in blood; | — |
Countries
China
Contacts
Public ContactLiu Hongmei
Rehabilitation Hospital, National Research Center for RehabilitationTechnical Aids
Outcome results
None listed